In defense of the metabolic syndrome

Journal of Clinical Lipidology

Volumn 3, Issue 4, 2009, Pages 247-249

  Whayne Jr , Thomas F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; EDITORIAL; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; HYPERINSULINEMIA; INCIDENCE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 68349128628     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2009.06.003     Document Type: Editorial

References (19)

1. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Cooper-DeHoff R.M., and Pepine C.J. Metabolic syndrome and cardiovascular disease: challenges and opportunities. Clin Cardiol 30 (2007) 593-597
3. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith Jr. S.C., Spertus J.A., and Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
4. Wang J., Ruotsalainen S., Moilanen L., Lepisto P., Laakso M., and Kuusisto J. The metabolic syndrome predicts incident stroke: a 14-year follow-up study in elderly people in Finland. Stroke 39 (2008) 1078-1083
5. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., and Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109 (2004) 42-46
6. Stolar M. Metabolic syndrome: controversial but useful. Cleve Clin J Med 74 (2007) 199-202 205-198
7. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., and Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112 (2005) 3066-3072
8. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
9. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
10. Daly C.A., Hildebrandt P., Bertrand M., Ferrari R., Remme W., Simoons M., and Fox K.M. Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial. Heart 93 (2007) 1406-1411
11. Bataille V., Perret B., Dallongeville J., Arveiler D., Yarnell J., Ducimetiere P., and Ferrieres J. Metabolic syndrome and coronary heart disease risk in a population-based study of middle-aged men from France and Northern Ireland. A nested case-control study from the PRIME cohort. Diabetes Metab 32 (2006) 475-479
12. Sukhija R., Aronow W.S., Yalamanchili K., Peterson S.J., Frishman W.H., and Babu S. Association of ankle-brachial index with severity of angiographic coronary artery disease in patients with peripheral arterial disease and coronary artery disease. Cardiology 103 (2005) 158-160
13. Maksimovic M, Vlajinac H, Radak D, Marinkovic J, Jorga J. Relationship between peripheral arterial disease and metabolic syndrome. Angiology. 2009 Feb 3. [Epub ahead of print].
14. Adolphe A., Cook L.S., and Huang X. A cross-sectional study of intima-media thickness, ethnicity, metabolic syndrome, and cardiovascular risk in 2268 study participants. Mayo Clin Proc 84 (2009) 221-228
15. Alexander C.M., Landsman P.B., Teutsch S.M., and Haffner S.M. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52 (2003) 1210-1214
16. Grundy S.M. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 47 (2006) 1093-1100
17. Takamiya T., Zaky W.R., Edmundowics D., Kadowaki T., Ueshima H., Kuller L.H., and Sekikawa A. World Health Organization-defined metabolic syndrome is a better predictor of coronary calcium than the adult treatment panel III criteria in American men aged 40-49 years. Diabetes Care 27 (2004) 2977-2979
18. Balkau B., and Charles M.A. Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16 (1999) 442-443
19. Metabolic syndrome: consensus from the International Diabetes Federation could stop the cardiovascular disease time bomb. Available at. http://www.idf.org/metabolic-syndrome Accessed June 18, 2009